Overview
Marie-eve Roy practices practicing medicine in Montreal, Canada.
Their clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marie-eve Roy
Is Marie-eve Roy a top-rated expert for Glioblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Marie-eve Roy is classified as an Experienced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marie-eve Roy participate in research or clinical trials?
Yes. Marie-eve Roy has published 13 articles and abstracts on conditions like Glioblastoma. You can view a list of Marie-eve Roy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaRoy isExperienced. Learn about Astrocytoma.
- Brain TumorRoy isExperienced. Learn about Brain Tumor.
- GlioblastomaRoy isExperienced. Learn about Glioblastoma.
- GliomaRoy isExperienced. Learn about Glioma.
- Gliomatosis CerebriRoy isExperienced. Learn about Gliomatosis Cerebri.
- Triple-Negative Breast Cancer